Drug & Device Manufacturers

Pharma-Funded Testosterone Courses Mislead Doctors

October 28, 2015
FDA Warns Manufacturers Linked to Superbug Outbreak

August 18, 2015
Zimmer to Boost Market Share with $13B Biomet Purchase

May 5, 2014
Eli Lilly Faces Financial Hurdles over Loss of Cymbalta Patent

January 2, 2014
Eli Lilly Switches Strategy: Quality Diabetes Drugs over Increased Sales Force

October 9, 2013
Johnson & Johnson to Discontinue Metal-on-Metal Hip Implants

May 24, 2013

Drugwatch Archives

Looking for an older news story? Search the Drugwatch archives for any of our published news posts by month and category.

Month

Category

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617